Autopsy report · NCT04003818

Efficacy and Safety of Teicoplanin in CDAD

“Due to COVID-19 and great challenges during patient enrolment period, current status of this study is far behind the plan. The study cannot be completed according to the plan. Sanofi decides to terminate the study upon comprehensive assessment.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 11 months before it started.
• Ran for about 10 months before it stopped.
• 50 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Sanofi

Sponsor type

Industry

Conditions

Clostridium Difficile Infection-associated Diarrhea and Colitis

Interventions

TEICOPLANIN

Participants

50

Sites

1

Countries

China

Trials that died the same way

• A Study to Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People With Weakened Immune Systems or at Increased Risk for Poor Outcomes Who Are Hospitalized Due to Severe COVID-19
  “Termination due to challenges related to the operational feasibility of the study, taking into account the current epidemiology and declining hospitalization rates for severe COVID-19.” (75% match in meaning)
• Acceptability, Feasibility and Safety of a Yoga Program for Chronic Pain in Sickle Cell Disease
  “Study terminated due to COVID-19 pandemic.” (72% match in meaning)
• Peripheral Nerve Stimulation for Back
  “Due to COVID-19 and other factors this study was terminated early and the patients currently enrolled are being used as a small pilot study.” (71% match in meaning)
• T-MACS Decision Aid: a Randomized, Controlled Point of Care Trial
  “CI no longer wishes to complete this study due to Covid-19” (71% match in meaning)
• Vitamin D Status and Bone Health of Older Adults in Care Facilities
  “COVID-19, study status being reviewed on an ongoing basis.” (71% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.